← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:726 | 726 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:726 | 726 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin; Hydroxocobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:726 | 726 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-1 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:726 | 726 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:726 | 726 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0740 | 5446-0740-01 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:726 | 726 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8100 | 71285-8100-1 | Heparin Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:726 | 726 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:726 | 726 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0423 | 71285-0423-1 | Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Threonine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:726 | 726 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3022 | 71286-3022-1 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:726 | 726 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:726 | 726 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:726 | 726 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:726 | 726 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-611 | 70092-611-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:726 | 726 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Liraglutide | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:726 | 726 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine Hydrochloride; Arginine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:727 | 727 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-032 | 70713-032-01 | TESTOSTERONE C 25MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:727 | 727 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8110 | 71266-8110-1 | Epinephrine | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:727 | 727 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin; Hydroxocobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:727 | 727 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-2 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:727 | 727 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:727 | 727 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:727 | 727 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:727 | 727 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6006 | 71286-6006-1 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:727 | 727 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:727 | 727 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-103 | 73463-103-06 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:727 | 727 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6487 | 71266-6487-5 | Iohexol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:727 | 727 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7427 | 72934-7427-6 | Levocetirizine Dihydrochloride; Clobetasol Propionate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:727 | 727 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:727 | 727 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-612 | 70092-612-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:727 | 727 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Liraglutide | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:727 | 727 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6010 | 72682-6010-1 | Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:728 | 728 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-630 | 71170-630-01 | Tirzepatide 60mg and Pyridoxine 12mg | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:728 | 728 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:728 | 728 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hyaluronidase | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:728 | 728 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-18 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:728 | 728 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:728 | 728 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:728 | 728 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7023 | 71285-7023-1 | Heparin Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:728 | 728 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:728 | 728 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:728 | 728 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:728 | 728 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6488 | 71266-6488-3 | Iohexol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:728 | 728 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5401 | 72934-5401-4 | Lidocaine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:728 | 728 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-120 | 73177-120-02 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:728 | 728 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-658 | 70092-658-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:728 | 728 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-614 | 81375-614-03 | Liraglutide | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:728 | 728 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2431 | 72627-2431-1 | Magnesium Chloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:729 | 729 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:729 | 729 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Bitartrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:729 | 729 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0980 | 5446-0980-01 | Hydrochloric Acid | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:729 | 729 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:729 | 729 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-30 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:729 | 729 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-05 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:729 | 729 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:729 | 729 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:729 | 729 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-111 | 73702-111-15 | Lidocaine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:729 | 729 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-433 | 70004-433-05 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:729 | 729 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isoproterenol Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:729 | 729 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6676 | 71300-6676-2 | Lidocaine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:729 | 729 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:729 | 729 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:729 | 729 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Liraglutide | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:729 | 729 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-158 | 73198-158-30 | Magnesium Chloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:730 | 730 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-27 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:730 | 730 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Bitartrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0457 | 5446-0457-03 | Hydrocortisone; Chloramphenicol; Sulfamethoxazole; Amphotericin B | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-2 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-18 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-03 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0429 | 72196-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:730 | 730 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:730 | 730 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-430 | 70004-430-09 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1398 | 72934-1398-2 | Ivermectin; Metronidazole | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:730 | 730 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-023 | 71449-023-11 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-663 | 70092-663-43 | Lidocaine Hydrochloride; Epinephrine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0061 | 81483-0061-0 | Lorazepam | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:730 | 730 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-141 | 73198-141-30 | Magnesium Chloride; Zinc Sulfate Heptahydrate; Copper Gluconate; Manganese Sulfate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:731 | 731 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-05 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:731 | 731 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Bitartrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:731 | 731 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:731 | 731 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:731 | 731 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-55 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:731 | 731 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:731 | 731 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:731 | 731 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:731 | 731 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:731 | 731 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-430 | 70004-430-12 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:731 | 731 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:731 | 731 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:731 | 731 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5480 | 26436-5480-1 | Lidocaine Hydrochloride Anhydrous | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:731 | 731 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-662 | 70092-662-43 | Lidocaine Hydrochloride; Epinephrine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:731 | 731 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-25 | Lorazepam | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:731 | 731 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Sulfate Heptahydrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:732 | 732 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-122 | 73177-122-01 | Atropine Sulfate | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:732 | 732 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:732 | 732 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:732 | 732 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0600 | 60652-0600-2 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:732 | 732 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:732 | 732 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:732 | 732 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:732 | 732 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:732 | 732 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:732 | 732 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-101 | 73177-101-27 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:732 | 732 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-068 | 71449-068-11 | Ketamine | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:732 | 732 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:732 | 732 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-164 | 63037-164-25 | Lidocaine Hydrochloride Anhydrous | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:732 | 732 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:732 | 732 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-13 | Lorazepam | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:732 | 732 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0219 | 72196-0219-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Sodium Bicarbonate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:733 | 733 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9684 | 71266-9684-5 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:733 | 733 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:733 | 733 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-16 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:733 | 733 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:733 | 733 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2012 | 71286-2012-1 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:733 | 733 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-317 | 69374-317-05 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:733 | 733 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hyaluronic Acid; Ascorbic Acid; Tretinoin | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:733 | 733 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:733 | 733 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:733 | 733 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-101 | 73177-101-06 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:733 | 733 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-068 | 71449-068-32 | Ketamine | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:733 | 733 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:733 | 733 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-162 | 63037-162-25 | Lidocaine Hydrochloride Anhydrous | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:733 | 733 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0037 | 81483-0037-0 | Lidocaine Hydrochloride; Epinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:733 | 733 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Loteprednol Etabonate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:733 | 733 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0205 | 71285-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:734 | 734 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-3 | NALTREXONE HYDROCHLORIDE | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:734 | 734 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:734 | 734 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-22 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:734 | 734 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:734 | 734 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-30 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:734 | 734 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-502 | 65302-502-03 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:734 | 734 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hyaluronic Acid; Tretinoin | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:734 | 734 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-119 | 73177-119-01 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:734 | 734 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:734 | 734 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-101 | 73177-101-02 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:734 | 734 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-301 | 73702-301-15 | Ketamine | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:734 | 734 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:734 | 734 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-486 | 68985-486-93 | Lidocaine Hydrochloride Anhydrous; Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:734 | 734 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6290 | 71266-6290-1 | Lidocaine Hydrochloride; Epinephrine Bitartrate; Tetracaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:734 | 734 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:734 | 734 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0205 | 72196-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:735 | 735 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-3 | NALTREXONE HYDROCHLORIDE | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:735 | 735 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:735 | 735 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-302 | 70004-302-22 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:735 | 735 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:735 | 735 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-22 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:735 | 735 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-502 | 65302-502-05 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:735 | 735 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1621 | 5446-1621-01 | Hyaluronidase-1 Bovine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:735 | 735 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:735 | 735 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:735 | 735 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-143 | 73177-143-27 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:735 | 735 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-2 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:735 | 735 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:735 | 735 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-611 | 70092-611-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:735 | 735 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:735 | 735 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0415 | 71285-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:735 | 735 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:736 | 736 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam 1 mg/ml in 100ml NS IVB | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:736 | 736 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:736 | 736 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-21 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:736 | 736 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:736 | 736 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-62 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:736 | 736 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-1 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:736 | 736 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:736 | 736 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-133 | 73177-133-03 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:736 | 736 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:736 | 736 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-27 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:736 | 736 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9081 | 71266-9081-1 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:736 | 736 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:736 | 736 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-658 | 70092-658-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:736 | 736 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-802 | 69194-802-01 | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:736 | 736 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0408 | 71285-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:736 | 736 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0111 | 72196-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:737 | 737 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-02 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:737 | 737 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:737 | 737 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:737 | 737 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-983 | 69374-983-50 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:737 | 737 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-17 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:737 | 737 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-792 | 76154-792-75 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:737 | 737 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3157 | 72627-3157-1 | Hydrocortisone; Hydroquinone; Tretinoin | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:737 | 737 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:737 | 737 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:737 | 737 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-28 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:737 | 737 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:737 | 737 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-111 | 73702-111-15 | Lidocaine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:737 | 737 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-612 | 70092-612-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:737 | 737 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-589 | 69194-589-01 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:737 | 737 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0406 | 72196-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:737 | 737 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:738 | 738 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-9 | NALTREXONE HYDROCHLORIDE | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:738 | 738 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:738 | 738 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-18 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:738 | 738 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-983 | 69374-983-30 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:738 | 738 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-21 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:738 | 738 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-2 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:738 | 738 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3127 | 72627-3127-1 | Hydrocortisone; Hydroquinone; Tretinoin | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:738 | 738 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:738 | 738 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 |